the issue imo is the difference between legal and

New Post Public Reply Private Reply Replies (3) Message Board
4kids petemantx #53656
288
the issue imo is the difference between legal and abusive
and how *handled/reported* by NR (non retail)

while difficult to do .. folks need to take emotions out of the equation
and think back to what was done on IPIX then CTIX
specific to time period of 2013/2014 .. i refer to this undertaking by NR
as working cycles of money .. and literally that works for NR until it doesn't

and that is why after IPIX (CTIX) saw the *run up to $4.96 (from memory so i may be off)
in late December 2014 .. the next round in play was the hand off for the reset back down

this is why i noted months back about the *volume* and the cost of those *trades*
re: *volume avgs*

so as NR struggled to work the round down from the run up ($4.96) .. IPIX (CTIX) was doing on avg 500,000 to 600,000 in *volume* at far higher price point than recent *rounds*

any way it is sliced .. for over 4 years now .. NR has relentlessly worked IPIX (CTIX) down

and has done so on less *volume* .. until of course 9.12.18

i'd noted in early September 2018 that NRs' struggle re: volume maintenance was signifiant (again total volume up thru EO August 2018 was running ..again from memory so may be off slightly .. 10M to 11M *less* than the same time frame of 2017) .. this was while PPS relentless compression was effectively cut in half from then 70c (and the reason imo it took NR so long to slice and dice was due to mgmt's cusip/ticker change out which imo delayed NRs' time frame) to approx 35c

i also noted that imo NR would have to address the volume deficiency because
NR imo had literally squeezed out retail traders .. retail rarely *legally shorts* an OTC .. however trading crews and NR does and will .. but that is just the icing on NRs' cake

Innovation Pharma filed their annual (K) AH's on 9.11.18 .. and *volume* was underway on 9.12.18 .. smarter folks than i suspected what NR gleaned was the term sheet included in the filing .. hard to know one way or the other if that was what triggered the *absurdly bizarre overkill re: IPIX's volume* over the next several months .. to the point where the *volume* YTD to EO August was *surpassed* significantly by the *volume* of 9.12.18 to 12.31.18 .. an oddity for sure

but with NRs' usual relentless playbook MO of compressing IPIX (mid 30c range to 7c from September 2018 to December 2018)

all the while .. most with interest could recognize that either IPIX (CTIX) was illegally manipulated UP at the EO 2014 .. or IPIX was being illegally manipulated
down afterward .. NR can't have it both ways .. so the ? imo actual investors had to ask themselves was .. has Innovation Pharma delivered measurable progress .. and if so is that progress today farther along now than in December 2014?

almost always (hate absolutes but imo this one fits) .. there are usually only 2 ways for an investor to be parted from their investment

one is to take the PPS high enough .. the other is to compress the PPS low enough


NR can and has timed efforts to NRs' trading crews .. which is why you see posts
starting in mid October *extolling* tax loss selling .. or BK .. or the usual incessant whining re: company's PPS .. as if the PPS wasn't the easiest aspect NR controls
>> literally <<

it's pretty clear the MO NR has executed against IPIX (CTIX) since 2015

at some point in September 2018 .. an *entity* or two figured out that *volume* needed to be injected .. which came as no surprise to me .. it's hard for multi/s
to scream *sells* 24/7/365 .. when IPIX's *volume* had gone cliff diving

this also pertains to *liquidity* (and imo for the most part .. not all .. it's bogus specific to volume engendered since 9.12.18)

think of 500000 in avg daily volume with a PPS of $2.50 .. that is $1,250,000.00
done daily dollar wise .. now take that same $1,250.000.00 with a .15c PPS and the daily volume avg works out to (approx) 8M and change .. something that even NR with their last round of *volume* injection didn't come close to

so as much as the multi/s and NR entities' scream and spew .. every investor (new or old) should imo understand 3 facts ..

Innovation's mgmt is clearly aware (and imo has been since their aggressive response of NRs' SOP BS of 2015) .. which matters imo specific to timing/sequence of mgmt's execution going forward

volume maintenance is a struggle for NR regardless of how compressed stock is worked
currently worth noting .. 10/90 day avgs (algos) @ approx 560,000~ per
showing that NRs' struggle remains an indication that investors remain *invested*
(imo NR is slowly but surely working IPIX upward .. but as previously noted doing
so *subtly* as to almost not be noticeable)

IPIX currently

Volume 198,512
Volume (10 day Average) 56 6,853
Volume (90 day Average) 56 2,283


last but not least .. Innovation's platform diversity .. which has to be the biggest gamble NR took against Innovation Pharma years back .. and imo has lost


i hope in my lifetime .. i see total transparency .. because i shudder to think of coming generations having no faith in a system so rotten .. that they either *trade* or never invest

i've watched too many legitimate companies be destroyed because of *greed*
imo the cost to our society overall is immense re: loss specific to technology/jobs/revenue/stability

at some point .. a rotten system collapses in total ..

and while there are no guarantees in this lifetime .. imo if one can understand
how and what NR does (why is easy .. it's $ and lots of it) and that includes targets/mgmts .. and one can truly recognize their own risk/reward tolerance ..
those who outlast/survive are usually epic in how handled .. and that *epic* aspect increases exponentially for each subsequent year of *outlasting/survival*

most targets .. don't



4kids

A seemingly simplistic (and unrealistic) solution would be for a stock to be able to ask that it be halted for trading for 3 days, thus all prior trades would have to be closed and at the end of the 3 day halt it would in effect have become a T+0 stock for that brief period of time, though that brief time would allow regulatory bodies time to see how many naked shares didn't get accounted for.

Wouldn't that square away the trades that are constantly being rotated thru the system allowing the naked shorts to survive?

Give just a 2 day notice prior to shutdown so investors needing money over that 3 day halt could sell some shares prior to shutdown if need be.

As stated above, obviously too simplistic an answer to the naked short problem but it would sure help put a lid on the outrageously allowed scam being perpetuated daily on the small retail investor.

Read More: https://investorshangout.com/post/newpost/873...z5hPk1pEwo


















Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 8

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 3

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 6

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 6

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 7

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 7

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading

Top 5 Most Recently Viewed Articles

Urbo Bankas Reports Strong Growth and Strategic Initiatives

Updated Category News Views 122

Urbo Bankas' Financial Performance Analysis Urbo Bankas UAB has demonstrated remarkable resilience and growth over the recent quarters. Based in Lithuania and recognized for their innovative banking solutions, the bank has reported impressive increases in both its loan and deposit portfolios, marking a significant achievement for the institution. Growth in Loans and...

Continue Reading
Latest Update on Signify's Share Buyback Program

Updated Category News Views 198

Signify's Share Repurchase Program Overview Signify (Euronext: LIGHT), recognized as the global leader in lighting solutions, has recently provided an important update on its share repurchase program. This initiative is key to the company’s commitment to returning value to its shareholders while strategically managing its equity. Recently, from May 19 to May 23, 2025,...

Continue Reading
ConnectOne Bancorp's Q3 Earnings: Merger Insights and Outlook

Updated Category News Views 215

ConnectOne Bancorp's Strategic Endeavors in the Third Quarter In a recent earnings call, ConnectOne Bancorp (NASDAQ: CNOB) revealed a merger with First of Long Island Corporation, aimed at significantly boosting the bank's market footprint and credit quality. This merger, anticipated to finalize in the first half of 2025, positions ConnectOne with assets exceeding $14...

Continue Reading
Creator Economy to Hit $1.34 Trillion by 2033

Updated Category News Views 4

From Trend to Digital Powerhouse Who’d have thought that a bunch of folks making videos in their bedrooms could morph into a billion-dollar market juggernaut? Yet, that's exactly what's happening with the creator economy. As it stands, this beast of a market is chomping through revenue like a hungry wolf in a sheep pen, soaring from a cool $252.33 billion in 2025 to an...

Continue Reading
Celebrating Rx Relief's Commitment to Women's Empowerment

Updated Category News Views 120

Rx Relief Receives Notable Recognition for Women's Empowerment In a remarkable achievement, Rx relief has been honored as one of the Best Staffing Firms for Women by ClearlyRated. This recognition highlights their commitment to fostering an inclusive and empowering environment for women within the organization. Such accolades serve as a testament to the dedication Rx...

Continue Reading